KR20140107547A - 피부 색소침착의 치료를 위한 조성물 - Google Patents

피부 색소침착의 치료를 위한 조성물 Download PDF

Info

Publication number
KR20140107547A
KR20140107547A KR1020147020349A KR20147020349A KR20140107547A KR 20140107547 A KR20140107547 A KR 20140107547A KR 1020147020349 A KR1020147020349 A KR 1020147020349A KR 20147020349 A KR20147020349 A KR 20147020349A KR 20140107547 A KR20140107547 A KR 20140107547A
Authority
KR
South Korea
Prior art keywords
bilirubin
extract
composition
producing plant
strelitzia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147020349A
Other languages
English (en)
Korean (ko)
Inventor
제임스 빈센트 그루버
필립 레뎃 러드윅
Original Assignee
론자 워커스빌 아이엔씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 론자 워커스빌 아이엔씨. filed Critical 론자 워커스빌 아이엔씨.
Publication of KR20140107547A publication Critical patent/KR20140107547A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728—Bilirubin; including biliverdin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/146666—Bile pigment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
KR1020147020349A 2011-12-22 2012-12-21 피부 색소침착의 치료를 위한 조성물 Ceased KR20140107547A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161579178P 2011-12-22 2011-12-22
US61/579,178 2011-12-22
PCT/EP2012/076589 WO2013092973A2 (en) 2011-12-22 2012-12-21 Composition for treating skin pigmentation

Publications (1)

Publication Number Publication Date
KR20140107547A true KR20140107547A (ko) 2014-09-04

Family

ID=47458981

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147020349A Ceased KR20140107547A (ko) 2011-12-22 2012-12-21 피부 색소침착의 치료를 위한 조성물

Country Status (5)

Country Link
US (2) US20130164234A1 (https=)
EP (1) EP2822660B1 (https=)
JP (1) JP6158219B2 (https=)
KR (1) KR20140107547A (https=)
WO (1) WO2013092973A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102300141B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 춘추 잠바
KR102300135B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 신발

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170296458A1 (en) * 2016-04-14 2017-10-19 The Procter & Gamble Company Cosmetic composition
CN110785161B (zh) 2017-06-23 2023-06-20 宝洁公司 用于改善皮肤外观的组合物和方法
US10874600B2 (en) * 2018-06-18 2020-12-29 The Procter & Gamble Company Method for degrading bilirubin in skin
CN112437657A (zh) 2018-07-03 2021-03-02 宝洁公司 处理皮肤状况的方法
US11786451B2 (en) 2019-06-28 2023-10-17 The Procter & Gamble Company Skin care composition
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
JP7590462B2 (ja) 2020-06-01 2024-11-26 ザ プロクター アンド ギャンブル カンパニー ビタミンｂ３化合物の皮膚への浸透を改善する方法
CN114588094A (zh) * 2022-02-23 2022-06-07 郭进平 一种具有祛痘印功效的护肤组合物及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2239345A (en) 1939-06-19 1941-04-22 Inst Divi Themae Foundation Proliferation stimulants and process of making same
US3067103A (en) * 1960-07-22 1962-12-04 James Y P Chen Healing-enhancing preparations comprising gardenia florida seed extract and pharmaceutically acceptable carrier formulations
GB1541463A (en) 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4960764A (en) 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
CH679012A5 (https=) * 1990-11-27 1991-12-13 Magdalena Mrak
CA2122923C (en) 1991-11-25 1999-01-19 Roy L. Blank Compositions for regulating skin wrinkles and/or skin atrophy
US5681852A (en) 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
US6607735B2 (en) * 2000-12-21 2003-08-19 Johnson & Johnson Consumer Companies, Inc. Method for reducing the appearance of dark circles under the eyes
US20030198682A1 (en) 2002-02-12 2003-10-23 Gruber James V. Composition and method for protecting labile active components during high temperature drying
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US9657257B2 (en) * 2007-05-10 2017-05-23 Kimberly-Clark Worldwide, Inc. Colorant neutralizer
FR2918885B1 (fr) 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR2930557B1 (fr) * 2008-04-29 2013-08-30 Lvmh Rech Matieres colorantes d'origine vegetale et leur utilisation pour colorer des compositions, en particulier des compositions cosmetiques
US20110250227A1 (en) * 2008-08-11 2011-10-13 Hanan Elraz Composition for treatment of the skin
US8178106B2 (en) * 2009-03-30 2012-05-15 Mary Kay Inc. Topical skin care formulations
US20090263435A1 (en) * 2009-05-07 2009-10-22 L'oreal S.A. Compositions and methods for minimizing and/or reducing the appearance of defects around eyes
FR2954698B1 (fr) * 2009-12-29 2015-10-23 Lvmh Rech Extrait de la plante ravenala madagascariensis et utilisation comme agent cosmetique hydratant
US20120045405A1 (en) * 2010-08-18 2012-02-23 Gilman Miles E Under eye cream
KR20240134399A (ko) * 2011-04-21 2024-09-09 마리 케이 인코포레이티드 식물 추출물을 포함하는 국소 스킨 케어 제형

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102300141B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 춘추 잠바
KR102300135B1 (ko) * 2021-02-03 2021-09-09 엠플러스에프엔씨(주) 밀리터리 패션 스타일 신발

Also Published As

Publication number Publication date
EP2822660B1 (en) 2017-01-18
WO2013092973A3 (en) 2014-12-31
EP2822660A2 (en) 2015-01-14
JP6158219B2 (ja) 2017-07-05
US10034830B2 (en) 2018-07-31
WO2013092973A2 (en) 2013-06-27
JP2015511211A (ja) 2015-04-16
US20150190337A1 (en) 2015-07-09
US20130164234A1 (en) 2013-06-27

Similar Documents

Publication Publication Date Title
KR20140107547A (ko) 피부 색소침착의 치료를 위한 조성물
JP7758679B2 (ja) ラベンダーの水性抽出物を得る方法、そのような抽出物を含む組成物、およびその化粧的使用
JP2011516585A (ja) スキンケア組成物およびその使用方法
CN106038342A (zh) 一种新型防晒、抗氧化、美白化妆品组合物及其制备方法
FR2928263A1 (fr) Procede de traitement cosmetique a base de polyphenols de fruits ou de legumes
JP2001122757A (ja) 活性酸素消去剤、抗酸化剤および化粧料
CN111450003A (zh) 含黄金香柳提取物的抗初老亮颜营养物及其制备方法和精华液、黄金香柳提取物的提取方法
JPH06336430A (ja) メイラード反応阻害剤
CN110623885A (zh) 一种抗糖基化的祛黄抗衰组合物及其制备方法与应用
US10363212B2 (en) Aesculus hippocastanum extract
KR102552681B1 (ko) 모발 염색용 조성물 및 이를 이용한 모발 염색 방법
KR101972123B1 (ko) 갈산 및 당단백질을 유효성분으로 포함하는 장미 추출물과 이의 제조방법, 및 이를 포함하는 화장료 조성물
KR20190137328A (ko) 병아리꽃나무 추출물을 포함하는 항노화용 피부외용제 조성물
EP3426276B1 (en) Synephrine compositions
SE543379C2 (en) Composition and formulation comprising a Persicaria Capitata plant extract
US20250017845A1 (en) Plant derived active ingredient comprising plant extracts
KR20130113474A (ko) 폴리페놀계 포도 추출물 및 그 추출물을 포함한 화장품
WO2019006453A1 (en) CAPILLARY TREATMENT COMPOSITIONS AND METHODS OF USE
EP2198848A2 (en) Compositions comprising self-tanning agents and sugar amines
CN113262191A (zh) 一种母菊花润肤面霜及其制备方法
EP3164193B1 (de) Verwendung von speziellen oligopeptiden zur stimulierung des natürlichen pigmentierungsprozesses in hautanhangsgebilden
JPH0249709A (ja) ログウッド抽出物含有メラニン生成抑制剤
KR102628074B1 (ko) 꿩의밥 추출물을 포함하는 항노화용 피부외용제 조성물
WO2024165515A1 (en) Liquid extract from sprigs and/or twigs of morus alba l. and related topical compositions for the prevention and treatment of skin ageing
KR101738009B1 (ko) 개오동나무 및 싸리나무 혼합추출물을 함유하는 화장료 조성물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20140721

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20160824

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20171219

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190222

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190526

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20190222

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I